Community contextual predictors of endoscopic colorectal cancer screening in the USA: spatial multilevel regression analysis

International Journal of Health Geographics

Volumn 9, Issue , 2010, Pages

  Mobley, Lee R ^a   Kuo, Tzy Mey ^a   Urato, Matthew ^a   Subramanian, Sujha ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; DISEASE CONTROL; REGIONAL PATTERN; REGRESSION ANALYSIS; SPATIAL ANALYSIS;

UNITED STATES;

AGED; ARTICLE; DEMOGRAPHY; FEMALE; FORECASTING; GASTROINTESTINAL ENDOSCOPE; HUMAN; INTESTINE TUMOR; MALE; MASS SCREENING; MIDDLE AGED; REGRESSION ANALYSIS; UNITED STATES; UTILIZATION REVIEW;

AGED; ENDOSCOPES, GASTROINTESTINAL; FEMALE; FORECASTING; HUMANS; INTESTINAL NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; REGRESSION ANALYSIS; RESIDENCE CHARACTERISTICS; UNITED STATES;

EID: 77956472017     PISSN: None     EISSN: 1476072X     Source Type: Journal    
DOI: 10.1186/1476-072X-9-44     Document Type: Article

References (52)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249. 10.3322/caac.20006, 19474385.
2. American Cancer Society (ACS) Cancer prevention and early detection facts and figures 2006 American Cancer Society (ACS)., http://www.cancer.org/Research/CancerFactsFigures/CancerPreventionEarlyDetectionFactsFigures/cancer-prevention-early-detection-facts-figures-2006
3. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006, 15:389-394. 10.1158/1055-9965.EPI-05-0678, 16492934.
4. Ata A, Elzey JD, Insaf TZ, Grau AM, Stain SC, Ahmed NU. Colorectal cancer prevention: adherence patterns and correlates of tests done for screening purposes within United States populations. Cancer Detect Prev 2006, 30:134-143. 10.1016/j.cdp.2006.02.003, 16638628.
5. Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 2004, 100:2093-2103. 10.1002/cncr.20276, 15139050.
6. Klabunde CN, Lanier D, Meissner HI, Breslau ES, Brown ML. Improving colorectal cancer screening through research in primary care settings. Med Care 2008, 46:S1-4. 10.1097/MLR.0b013e3181805e2a, 18725819.
7. National Cancer Institute (NCI) NCI SEER Cancer Statistics Review 1975-2007 National Cancer Institute (NCI)., http://seer.cancer.gov/csr/1975_2007/browse_csr.php?section=1&page=sect_01_table.25
8. Administration on Aging (AA) Federal interagency forum on aging-related statistics: older Americans update 2006: key indicators of well-being. Administration on Aging (AA)., http://www.aoa.gov/agingstatsdotnet/Main_Site/Data/2006_Documents/OA_2006.pdf
9. Hetzel L, Smith A. The 65 years and over population: 2000. Census 2000 brief, C2KBR/01-10 2001, Washington, DC: United States Census Bureau., http://www.census.gov/prod/2001pubs/c2kbr01-10.pdf
10. Brenner H. Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods. Z Gastroenterol 2008, 46(Suppl 1):S20-22. 10.1055/s-2007-963481, 18368634.
11. O'Leary BA, Olynyk JK, Neville AM, Platell CF. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. J Gastroenterol Hepatol 2004, 19:38-47. 10.1111/j.1440-1746.2004.03177.x, 14675241.
12. Loeve F, Brown ML, Boer R, van Ballegooijen M, van Oortmarssen GJ, Habbema JD. Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst 2000, 92:557-563. 10.1093/jnci/92.7.557, 10749911.
13. Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst 2009, 101:1412-1422. 10.1093/jnci/djp319, 19779203.
14. Cooper GS, Koroukian SM. Geographic variation among Medicare beneficiaries in the use of colorectal carcinoma screening procedures. Am J Gastroenterol 2004, 99:1544-1550. 10.1111/j.1572-0241.2004.30902.x, 15307875.
15. Ko CW, Kreuter W, Baldwin LM. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement. BMC Gastroenterol 2005, 5:10. 10.1186/1471-230X-5-10, 555744, 15755323.
16. Loeve F, Brown ML, Boer R, Habbema JD. Re: improving the cost-effectiveness of colorectal cancer screening. J Natl Cancer Inst 2000, 92:1691-1692. 10.1093/jnci/92.20.1691, 11036117.
17. Schneider EC, Rosenthal M, Gatsonis CG, Zheng J, Epstein AM. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?. Med Care 2008, 46:S84-90. 10.1097/MLR.0b013e31817fdf80, 18725838.
18. Songster CL, Barrows GH, Jarrett DD. Immunochemical detection of fecal occult blood--the fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer. Cancer 1980, 45:1099-1102. 10.1002/1097-0142(19800315)45:5+<1099::AID-CNCR2820451312>3.0.CO;2-T, 6965607.
19. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008, 149:638-658.
20. Nadel MR, Berkowitz Z, Klabunde CN, Smith RA, Coughlin SS, White MC. Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations. J Gen Intern Med 2010, 25:833-839. 10.1007/s11606-010-1328-7, 2896587, 20383599.
21. Baker LC. Managed care spillover effects. Annu Rev Public Health 2003, 24:435-456. 10.1146/annurev.publhealth.24.100901.141000, 12471276.
22. Mobley L, Kuo TM, Urato M, Boos J, Lozano-Gracia N, Anselin L. Predictors of endoscopic colorectal cancer screening over time in 11 states. Cancer Causes Control 2010, 21:445-461. 10.1007/s10552-009-9476-y, 19946738.
23. Koroukian SM, Litaker D, Dor A, Cooper GS. Use of preventive services by Medicare fee-for-service beneficiaries: does spillover from managed care matter?. Med Care 2005, 43:445-452. 10.1097/01.mlr.0000160376.42562.79, 15838408.
24. Nelson DE, Powell-Griner E, Town M, Kovar MG. A comparison of national estimates from the National Health Interview Survey and the Behavioral Risk Factor Surveillance System. Am J Public Health 2003, 93:1335-1341. 10.2105/AJPH.93.8.1335, 1447966, 12893624.
25. Hiatt RA, Klabunde C, Breen N, Swan J, Ballard-Barbash R. Cancer screening practices from National Health Interview Surveys: past, present, and future. J Natl Cancer Inst 2002, 94:1837-1846.
26. Tangka FK, Molinari NA, Chattopadhyay SK, Seeff LC. Market for colorectal cancer screening by endoscopy in the United States. Am J Prev Med 2005, 29:54-60. 10.1016/j.amepre.2005.03.006, 15958253.
27. Lees KA, Wortley PM, Coughlin SS. Comparison of racial/ethnic disparities in adult immunization and cancer screening. Am J Prev Med 2005, 29:404-411. 10.1016/j.amepre.2005.08.009, 16376703.
28. Lewis JD, Asch DA. Barriers to office-based screening sigmoidoscopy: does reimbursement cover costs?. Ann Intern Med 1999, 130:525-530.
29. Balluz L, Ahluwalia IB, Murphy W, Mokdad A, Giles W, Harris VB. Surveillance for certain health behaviors among selected local areas--United States, Behavioral Risk Factor Surveillance System, 2002. MMWR Surveill Summ 2004, 53:1-100.
30. Seeff LC, Manninen DL, Dong FB, Chattopadhyay SK, Nadel MR, Tangka FK, Molinari NA. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?. Gastroenterology 2004, 127:1661-1669. 10.1053/j.gastro.2004.09.052, 15578502.
31. Levin TR. Colonoscopy capacity: Can we build it? Will they come?. Gastroenterology 2004, 127:1841-1844. 10.1053/j.gastro.2004.10.014, 15578522.
32. Pollack LA, Blackman DK, Wilson KM, Seeff LC, Nadel MR. Colorectal cancer test use among Hispanic and non-Hispanic U.S. populations. Prev Chronic Dis 2006, 3:A50. 1563962, 16539791.
33. Greiner KA, Engelman KK, Hall MA, Ellerbeck EF. Barriers to colorectal cancer screening in rural primary care. Prev Med 2004, 38:269-275. 10.1016/j.ypmed.2003.11.001, 14766108.
34. Ladabaum U, Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology 2005, 129:1151-1162. 10.1053/j.gastro.2005.07.059, 16230069.
35. Vijan S, Inadomi J, Hayward RA, Hofer TP, Fendrick AM. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment Pharmacol Ther 2004, 20:507-515. 10.1111/j.1365-2036.2004.01960.x, 15339322.
36. Goodman DC, Mick SS, Bott D, Stukel T, Chang CH, Marth N, Poage J, Carretta HJ. Primary care service areas: a new tool for the evaluation of primary care services. Health Serv Res 2003, 38:287-309. 10.1111/1475-6773.00116, 1360885, 12650392.
37. Mobley LR, Kuo TM, Andrews L. How sensitive are multilevel regression findings to defined area of context?: a case study of mammography use in California. Med Care Res Rev 2008, 65:315-337. 10.1177/1077558707312501, 2678861, 18259047.
38. Coughlin SS, Costanza ME, Fernandez ME, Glanz K, Lee JW, Smith SA, Stroud L, Tessaro I, Westfall JM, Weissfeld JL, Blumenthal DS. CDC-funded intervention research aimed at promoting colorectal cancer screening in communities. Cancer 2006, 107:1196-1204. 10.1002/cncr.22017, 16802326.
39. Townsend JS, Richardson LC, Steele CB, White DE. Evidence-based interventions and screening recommendations for colorectal cancer in comprehensive cancer control plans: a content analysis. Prev Chronic Dis 2009, 6:A127. 2774641, 19755003.
40. Greenwald L, Pope G, Anderson W, Mobley L, West N, Bernard S, Kautter J, Root E. Medicare preferred provider organization (PPO) case study and implementation report. Final Report 2004, Prepared for the Centers for Medicare & Medicaid Services (RTI Project Number 0207964.005). Available August 25, 2010., http://www.cms.hhs.gov/DemoProjectsEvalRpts/downloads/PPO_Implementation_Report.pdf
41. Pope GC, Greenwald L, Kautter J, Olmsted E, Mobley L. Medicare preferred provider organization demonstration: plan offerings and beneficiary enrollment. Health Care Financ Rev 2006, 27:95-109.
42. Hardin J, Hilbe J. Generalized Estimating Equations. 2003, New York: Chapman & Hal/CRC.
43. Horton N, Lipsitz S. Review of software to fit generalized estimation equation regression models. American Stat 1999, 53:60-169.
44. Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika 1986, 73:13-22.
45. New York Times (NYT) In Hawaii's health system: lessons for lawmakers. 2009, New York: Available online June 15, 2010, New York Times (NYT)., http://www.nytimes.com/2009/10/17/health/policy/17hawaii.html
46. Centers for Disease Control and Prevention (CDC) CRCCP program contact information. Centers for Disease Control and Prevention (CDC)., http://www.cdc.gov/cancer/crccp/contacts.htm
47. Chernew M, Decicca P, Town R. Managed care and medical expenditures of Medicare beneficiaries. J Health Econ 2008, 27:1451-1461. 10.1016/j.jhealeco.2008.07.014, 18801588.
48. Riley GF, Warren JL, Potosky AL, Klabunde CN, Harlan LC, Osswald MB. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans. Med Care 2008, 46:1108-1115. 10.1097/MLR.0b013e3181862565, 18815533.
49. Office of Management and Budget (OMB) Memorandum: developing effective place-based policies for the FY 2011 budget. 2009, Accessed online March 2010, Office of Management and Budget (OMB)., http://www.whitehouse.gov/omb/assets/memoranda_fy2009/m09-28.pdf
50. Guessous I, Dash C, Lapin P, Doroshenk M, Smith RA, Klabunde CN. Colorectal cancer screening barriers and facilitators in older persons. Prev Med 2010, 50:3-10. 10.1016/j.ypmed.2009.12.005, 20006644.
51. Ko CW, Sonnenberg A. Comparing risks and benefits of colorectal cancer screening in elderly patients. Gastroenterology 2005, 129:1163-1170. 10.1053/j.gastro.2005.07.027, 16230070.
52. Massey DS, Denton NA. The dimensions of residential segregation. Social Forces 1998, 7:281-315.